Wouter Remkes

1.4k total citations · 1 hit paper
16 papers, 461 citations indexed

About

Wouter Remkes is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wouter Remkes has authored 16 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 13 papers in Surgery and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wouter Remkes's work include Coronary Interventions and Diagnostics (13 papers), Cardiac Imaging and Diagnostics (10 papers) and Acute Myocardial Infarction Research (8 papers). Wouter Remkes is often cited by papers focused on Coronary Interventions and Diagnostics (13 papers), Cardiac Imaging and Diagnostics (10 papers) and Acute Myocardial Infarction Research (8 papers). Wouter Remkes collaborates with scholars based in Netherlands, Spain and United States. Wouter Remkes's co-authors include Frederik M. Zimmermann, Nico H.J. Pijls, Victor Legrand, Lokien X. van Nunen, Nils P. Johnson, Per Albertsson, G. Jan Willem Bech, Raimund Erbel, Pieter R. Stella and Angela Ferrara and has published in prestigious journals such as European Heart Journal, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

Wouter Remkes

15 papers receiving 456 citations

Hit Papers

Deferral vs. performance of percutaneous coronary interve... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial
    2015 305 citations Frederik M. Zimmermann, Angela Ferrara et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wouter Remkes Netherlands 7 376 329 288 48 38 16 461
Vithaya Chaithiraphan United States 9 158 0.4× 172 0.5× 300 1.0× 40 0.8× 28 0.7× 14 370
Helmut Gehlmann Netherlands 12 134 0.4× 140 0.4× 239 0.8× 46 1.0× 8 0.2× 27 320
Alessio Lilli Italy 12 128 0.3× 120 0.4× 398 1.4× 30 0.6× 56 1.5× 37 514
David Kassop United States 7 135 0.4× 75 0.2× 223 0.8× 33 0.7× 33 0.9× 11 295
A. Elhendy Netherlands 9 146 0.4× 326 1.0× 305 1.1× 22 0.5× 8 0.2× 16 445
Mitsunori Abe Japan 11 102 0.3× 142 0.4× 219 0.8× 35 0.7× 7 0.2× 26 351
Hironori Uzuka Japan 10 168 0.4× 140 0.4× 219 0.8× 17 0.4× 10 0.3× 14 303
Kazuma Ohyama Japan 8 157 0.4× 148 0.4× 215 0.7× 18 0.4× 14 0.4× 26 301
Ricardo D’Oliveira Vieira Brazil 7 188 0.5× 64 0.2× 191 0.7× 46 1.0× 13 0.3× 13 276
Eloisa Basile Italy 9 227 0.6× 221 0.7× 229 0.8× 11 0.2× 7 0.2× 27 344

Countries citing papers authored by Wouter Remkes

Since Specialization
Citations

This map shows the geographic impact of Wouter Remkes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter Remkes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter Remkes more than expected).

Fields of papers citing papers by Wouter Remkes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter Remkes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter Remkes. The network helps show where Wouter Remkes may publish in the future.

Co-authorship network of co-authors of Wouter Remkes

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter Remkes. A scholar is included among the top collaborators of Wouter Remkes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter Remkes. Wouter Remkes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Vlaar, Pieter J., J.P. van Kuijk, Maarten A. Vink, et al.. (2023). Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study. American Heart Journal. 266. 168–175. 4 indexed citations
3.
4.
Roolvink, Vincent, Jan Paul Ottervanger, Borja Ibáñez, et al.. (2018). One-year clinical outcome of early administration of intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary reperfusion. EuroIntervention. 14(6). 688–691. 5 indexed citations
5.
6.
7.
Badings, Erik, Wouter Remkes, Salem H.K. The, et al.. (2017). Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome. Open Heart. 4(1). e000538–e000538. 3 indexed citations
8.
Kennedy, Mark, Rik Hermanides, E. Kaplan, et al.. (2016). Fractional Flow Reserve–Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus. The American Journal of Cardiology. 118(9). 1293–1299. 17 indexed citations
9.
Badings, Erik, Wouter Remkes, Salem H.K. The, et al.. (2016). Timing of intervention in high-risk non-ST-elevation acute coronary syndromes in PCI versus non-PCI centres. Netherlands Heart Journal. 24(3). 181–187. 5 indexed citations
10.
Kennedy, Mark, E. Kaplan, Rik Hermanides, et al.. (2016). Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus. Cardiovascular Diabetology. 15(1). 100–100. 30 indexed citations
11.
Remkes, Wouter, Erik Badings, Renicus S. Hermanides, et al.. (2016). Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction. Open Heart. 3(2). e000455–e000455. 8 indexed citations
12.
Badings, Erik, Wouter Remkes, Salem H.K. The, et al.. (2016). Early or late intervention in patients with transient ST‐segment elevation acute coronary syndrome: Subgroup analysis of the ELISA‐3 trial. Catheterization and Cardiovascular Interventions. 88(5). 755–764. 12 indexed citations
13.
Zimmermann, Frederik M., Angela Ferrara, Nils P. Johnson, et al.. (2015). Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. European Heart Journal. 36(45). 3182–3188. 305 indexed citations breakdown →
14.
Remkes, Wouter, Samer Somi, Vincent Roolvink, et al.. (2014). Direct Drug-Eluting Stenting to Reduce Stent Restenosis. JACC: Cardiovascular Interventions. 7(7). 751–758. 6 indexed citations
15.
Remkes, Wouter, Samer Somi, Vincent Roolvink, et al.. (2013). A comparison of 2 second generation drug eluting stents (Zotarolimus versus Everolimus), in elective PCI patients. European Heart Journal. 34(suppl 1). P3028–P3028. 1 indexed citations
16.
Fiebrich, Helle‐Brit, Ester Siemerink, Adrienne H. Brouwers, et al.. (2011). Everolimus Induces Rapid Plasma Glucose Normalization in Insulinoma Patients by Effects on Tumor As Well As Normal Tissues. The Oncologist. 16(6). 783–787. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vithaya Chaithiraphan Breakdown of academic impact, for papers by Helmut Gehlmann Breakdown of academic impact, for papers by Alessio Lilli Breakdown of academic impact, for papers by David Kassop Breakdown of academic impact, for papers by A. Elhendy Breakdown of academic impact, for papers by Mitsunori Abe Breakdown of academic impact, for papers by Hironori Uzuka Breakdown of academic impact, for papers by Kazuma Ohyama Breakdown of academic impact, for papers by Ricardo D’Oliveira Vieira Breakdown of academic impact, for papers by Eloisa Basile
Rankless by CCL
2026